GSK-3beta Inhibitor21 (compound 44) is an ATP-competitive inhibitor of GSK-3beta with an IC50 value of 6.06 µM, characterized by its ability to inhibit tau phosphorylation and prevent amyloid protein aggregation. This compound is utilized in the research of Alzheimers disease.
Target-Kategorie:
GSK-3|||Microtubule Associated
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
